logo
Select company
Select metric
$ 3.21MPreferred Dividends Income Statement Impact
VS
Market
93
Sector
97
Industry
97
History
92
$ 2.52Close
$ 2 - $ 29.07 52-Week Range
Ticker Information

Ticker

BBLG

Company Name

BONE BIOLOGICS CORP

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

BONE BIOLOGICS CORP - Preferred Dividends Income Statement Impact Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BBLG - Pref. Div. Historical data
DatePreferred Dividends Income Statement Impact
6/30/2025$ 3.21M
3/31/2025$ 3.21M
12/31/2024$ 3.21M
9/30/2024$ 3.21M
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BONE BIOLOGICS CORP's latest trailing twelve months (TTM) Pref. Div. stands at $ 0.
  • Over the past 5 years, BONE BIOLOGICS CORP's average Pref. Div. has been $ 676.32K.
  • The median Pref. Div. for BONE BIOLOGICS CORP during this period was $ 0
  • BONE BIOLOGICS CORP reached its highest Pref. Div. over the past 5 years at $ 3.21M.
  • The lowest Pref. Div. recorded by BONE BIOLOGICS CORP in the same timeframe $ 0

Definition of Preferred Dividends Income Statement Impact

[Income Statement] The sum of dividends paid to preferred stockholders. To reflect the earnings available for common stockholders [NetIncCmn], dividends on preferred stock will be reported on the income statement as a reduction from net income [NetInc].

BBLG - Preferred Dividends Income Statement Impact, Last 5 years

$ 0

Minimum

Dec 31, 2020

$ 3.21M

Maximum

Sep 30, 2024

$ 676.32K

Average

$ 0

Median

Pref. Div. Benchmark Analysis

The chart above depicts the distribution of Pref. Div. for companies in the Total Stock Market. The average Pref. Div. of the companies is $ 9.97M with a standard deviation of $ 298.58M.
The following table provides additional summary stats:
Pref. Div. in the Market:
filtered constituents4.26K
min$ -2.19B
max$ 15.15B
average$ 9.97M
median$ 0
std$ 298.58M